A recent clinical study using autologous cell transplantation of peripheral blood-derived CD34+ cells in 43 patients with cardiomyopathy highlighted that higher expression levels of TERT in cell therapeutics improved their therapeutic effect against cardiovascular illnesses [26], suggesting that potential TERT gene transfer by vectors is a promising strategy to enhance the efficacy of cell therapeutics. This evidence concerns the gene TERT and cardiomyopathy.